359 related articles for article (PubMed ID: 20131241)
1. Endothelin 1 contributes to the effect of transforming growth factor beta1 on wound repair and skin fibrosis.
Lagares D; García-Fernández RA; Jiménez CL; Magán-Marchal N; Busnadiego O; Lamas S; Rodríguez-Pascual F
Arthritis Rheum; 2010 Mar; 62(3):878-89. PubMed ID: 20131241
[TBL] [Abstract][Full Text] [Related]
2. Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblasts.
Zhou X; Tan FK; Guo X; Wallis D; Milewicz DM; Xue S; Arnett FC
Arthritis Rheum; 2005 Jan; 52(1):257-61. PubMed ID: 15641096
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
4. Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model.
Stegemann A; Sindrilaru A; Eckes B; del Rey A; Heinick A; Schulte JS; Müller FU; Grando SA; Fiebich BL; Scharffetter-Kochanek K; Luger TA; Böhm M
Arthritis Rheum; 2013 Mar; 65(3):792-804. PubMed ID: 23440693
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
Avouac J; Palumbo K; Tomcik M; Zerr P; Dees C; Horn A; Maurer B; Akhmetshina A; Beyer C; Sadowski A; Schneider H; Shiozawa S; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
[TBL] [Abstract][Full Text] [Related]
6. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis.
Huber LC; Distler JH; Moritz F; Hemmatazad H; Hauser T; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Distler O; Jüngel A
Arthritis Rheum; 2007 Aug; 56(8):2755-64. PubMed ID: 17665426
[TBL] [Abstract][Full Text] [Related]
7. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.
Akamata K; Asano Y; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sato S
Arthritis Res Ther; 2014 Apr; 16(2):R86. PubMed ID: 24708674
[TBL] [Abstract][Full Text] [Related]
8. Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis.
Kapoor M; McCann M; Liu S; Huh K; Denton CP; Abraham DJ; Leask A
Arthritis Rheum; 2009 Sep; 60(9):2822-9. PubMed ID: 19714649
[TBL] [Abstract][Full Text] [Related]
9. Mediation of interleukin-1beta-induced transforming growth factor beta1 expression by activator protein 4 transcription factor in primary cultures of bovine articular chondrocytes: possible cooperation with activator protein 1.
Andriamanalijaona R; Felisaz N; Kim SJ; King-Jones K; Lehmann M; Pujol JP; Boumediene K
Arthritis Rheum; 2003 Jun; 48(6):1569-81. PubMed ID: 12794825
[TBL] [Abstract][Full Text] [Related]
10. Differential gene expression in response to transforming growth factor-beta1 by fetal and postnatal dermal fibroblasts.
Rolfe KJ; Irvine LM; Grobbelaar AO; Linge C
Wound Repair Regen; 2007; 15(6):897-906. PubMed ID: 18028139
[TBL] [Abstract][Full Text] [Related]
11. Construction of recombinant adenovirus co-expression vector carrying the human transforming growth factor-beta1 and vascular endothelial growth factor genes and its effect on anterior cruciate ligament fibroblasts.
Wei XL; Lin L; Hou Y; Fu X; Zhang JY; Mao ZB; Yu CL
Chin Med J (Engl); 2008 Aug; 121(15):1426-32. PubMed ID: 18959121
[TBL] [Abstract][Full Text] [Related]
12. Human xylosyltransferase-I - a new marker for myofibroblast differentiation in skin fibrosis.
Faust I; Roch C; Kuhn J; Prante C; Knabbe C; Hendig D
Biochem Biophys Res Commun; 2013 Jul; 436(3):449-54. PubMed ID: 23747722
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
14. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
15. Effects of endothelin-1 on fibroblasts from type 2 diabetic patients: Possible role in wound healing and tissue repair.
Solini A; Santini E; Madec S; Cuccato S; Ferrannini E
Growth Factors; 2007 Dec; 25(6):392-9. PubMed ID: 18365870
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor beta1-mediated activation of intestinal fibroblasts.
Burke JP; Watson RW; Murphy M; Docherty NG; Coffey JC; O'Connell PR
Br J Surg; 2009 May; 96(5):541-51. PubMed ID: 19358180
[TBL] [Abstract][Full Text] [Related]
17. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
18. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
[TBL] [Abstract][Full Text] [Related]
20. CCN2 is required for bleomycin-induced skin fibrosis in mice.
Liu S; Shi-wen X; Abraham DJ; Leask A
Arthritis Rheum; 2011 Jan; 63(1):239-46. PubMed ID: 20936632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
